skip to main content

Chemistry, part 2

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > imidazopyrimidine > purines > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > imidazopyrimidine > purines > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > imidazopyrimidine > purines > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > imidazopyrimidine > purines > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > imidazopyrimidine > purines > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > imidazopyrimidine > purines > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heterobicyclic compound > imidazopyrimidine > purines > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic aromatic compound > heteroarene > imidazopyrimidine > purines > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > imidazopyrimidine > purines > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > imidazopyrimidine > purines > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > heteroarene > imidazopyrimidine > purines > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > imidazopyrimidine > purines > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > imidazopyrimidine > purines > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > n-glycosyl compound > nucleoside > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > n-glycosyl compound > nucleoside > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > glycosyl compound > n-glycosyl compound > nucleoside > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > organooxygen compound > oxacycle > oxolanes > nucleoside > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > oxolanes > nucleoside > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxolanes > nucleoside > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > oxolanes > nucleoside > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxolanes > nucleoside > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxolanes > nucleoside > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteromonocyclic compound > oxolanes > nucleoside > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > nucleobase-containing molecular entity > nucleoside > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic aromatic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic aromatic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > heteroarene > nucleobase-containing molecular entity > nucleoside > purine nucleoside > (2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide

Preferred term

(2s,3r,5r)-3,4-dihydroxy-5-[6-[(3-iodophenyl)methylamino]-9-purinyl]-n-methyl-2-oxolanecarboxamide  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C18H19IN6O4

inchi

  • InChI=1S/C18H19IN6O4/c1-20-17(28)14-12(26)13(27)18(29-14)25-8-24-11-15(22-7-23-16(11)25)21-6-9-3-2-4-10(19)5-9/h2-5,7-8,12-14,18,26-27H,6H2,1H3,(H,20,28)(H,21,22,23)/t12-,13?,14+,18-/m1/s1

inchikey

  • HUJXGQILHAUCCV-FEWYLQRLSA-N

mass

  • 510.286

monoisotopicmass

  • 510.05125

smiles

  • CNC(=O)[C@@H]1[C@@H](C([C@@H](O1)N2C=NC3=C2N=CN=C3NCC4=CC(=CC=C4)I)O)O

subset

  • 2_STAR

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:91733

Download this concept:

RDF/XML TURTLE JSON-LD